Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) EPS (Weighted Average and Diluted) (2019 - 2025)

TELA Bio has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at -$0.17 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.17 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was -$0.83 (up 37.59% YoY), and the annual figure for FY2025 was -$0.83, up 37.59%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.17 at TELA Bio, up from -$0.19 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for TELA hit a ceiling of -$0.17 in Q4 2025 and a floor of -$0.88 in Q2 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.5 (2022), compared with a mean of -$0.46.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 54.39% in 2022 and later soared 67.92% in 2024.
  • TELA Bio's EPS (Weighted Average and Diluted) stood at -$0.59 in 2021, then rose by 18.64% to -$0.48 in 2022, then fell by 10.42% to -$0.53 in 2023, then soared by 67.92% to -$0.17 in 2024, then grew by 0.0% to -$0.17 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.17 (Q4 2025), -$0.19 (Q3 2025), and -$0.22 (Q2 2025) per Business Quant data.